Skip to main content

Sony, Maven Reach Consumables Development Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sony DADC and Maven Biotechnologies announced Wednesday a collaboration to develop and manufacture smart consumables for Maven's platform for performing cell-based assays and multiplexed biomarker detection.

Maven received a $1.96 million grant from the National Institute for Allergy and Infectious Disease in 2010 to commercialize the platform called Label-Free Internal Reflection Ellipsometry.

"The collaboration with Maven provides a perfect example of how we can translate our experience in micro-structured engineering, gained through our pioneering optical disc work, to the needs of the life sciences industry," Ali Tinazli, Sony DADC's director of business development and sales for North America, said in a statement.

Financial and other terms of the deal were not disclosed.

The deal is Sony DADC's fourth in recent months in the life science tools space. Last week, it announced a development deal with Anagnostics, and during the summer it reached agreements with Quanterix and RainDance Technologies.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.